INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 138 filers reported holding INOVIO PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.05 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2023 | $170,169 | +32.4% | 333,665 | +1.0% | 0.00% | – |
Q3 2023 | $128,556 | -7.1% | 330,477 | +6.6% | 0.00% | – |
Q2 2023 | $138,410 | -52.2% | 309,988 | -12.2% | 0.00% | – |
Q1 2023 | $289,558 | -28.3% | 353,120 | +36.4% | 0.00% | – |
Q4 2022 | $403,922 | -5.6% | 258,924 | +4.3% | 0.00% | – |
Q3 2022 | $428,000 | -2.1% | 248,253 | -1.8% | 0.00% | – |
Q2 2022 | $437,000 | -44.2% | 252,718 | +15.9% | 0.00% | – |
Q1 2022 | $783,000 | +96.2% | 218,103 | +173.0% | 0.00% | – |
Q4 2021 | $399,000 | -39.7% | 79,877 | -13.7% | 0.00% | – |
Q3 2021 | $662,000 | -15.1% | 92,556 | +9.9% | 0.00% | – |
Q2 2021 | $780,000 | +71.4% | 84,184 | +71.8% | 0.00% | – |
Q1 2021 | $455,000 | +55.8% | 49,001 | +48.7% | 0.00% | – |
Q4 2020 | $292,000 | -31.9% | 32,959 | -10.7% | 0.00% | – |
Q3 2020 | $429,000 | -88.7% | 36,906 | -73.7% | 0.00% | -100.0% |
Q2 2020 | $3,786,000 | +287.5% | 140,509 | +6.9% | 0.00% | – |
Q1 2020 | $977,000 | +608.0% | 131,389 | +214.4% | 0.00% | – |
Q4 2019 | $138,000 | +51.6% | 41,787 | -6.3% | 0.00% | – |
Q3 2019 | $91,000 | -33.1% | 44,613 | -3.8% | 0.00% | – |
Q2 2019 | $136,000 | -67.0% | 46,353 | -58.0% | 0.00% | – |
Q1 2019 | $412,000 | +80.7% | 110,328 | +93.4% | 0.00% | – |
Q4 2018 | $228,000 | -40.5% | 57,048 | -17.3% | 0.00% | – |
Q3 2018 | $383,000 | +88.7% | 68,957 | +33.0% | 0.00% | – |
Q2 2018 | $203,000 | +133.3% | 51,829 | +180.3% | 0.00% | – |
Q1 2018 | $87,000 | +27.9% | 18,489 | +12.2% | 0.00% | – |
Q4 2017 | $68,000 | -32.7% | 16,472 | +3.3% | 0.00% | – |
Q3 2017 | $101,000 | -13.7% | 15,944 | +6.8% | 0.00% | – |
Q2 2017 | $117,000 | -98.4% | 14,924 | -98.1% | 0.00% | -100.0% |
Q3 2016 | $7,431,000 | +20.0% | 797,317 | +19.0% | 0.00% | +50.0% |
Q2 2016 | $6,191,000 | +123720.0% | 670,030 | +110283.9% | 0.00% | – |
Q2 2015 | $5,000 | -94.0% | 607 | -92.8% | 0.00% | – |
Q3 2014 | $83,000 | -33.6% | 8,389 | -27.3% | 0.00% | – |
Q2 2014 | $125,000 | – | 11,546 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
STONERIDGE INVESTMENT PARTNERS LLC | 521,775 | $4,258,000 | 0.53% |
Round Table Services, LLC | 73,500 | $600,000 | 0.47% |
Cheyne Capital Management (UK) LLP | 160,000 | $1,305,000 | 0.42% |
SABBY MANAGEMENT, LLC | 906,000 | $7,393,000 | 0.27% |
Bellevue Asset Management AG | 200,000 | $1,632,000 | 0.23% |
GLOBEFLEX CAPITAL L P | 122,000 | $996,000 | 0.18% |
WASATCH ADVISORS LP | 1,959,114 | $15,986,000 | 0.17% |
EMERALD ADVISERS, LLC | 288,486 | $2,354,000 | 0.11% |
Rotella Capital Management, Inc. | 13,840 | $113,000 | 0.09% |
Catalyst Capital Advisors LLC | 65,000 | $530,000 | 0.06% |